ArticleProceedings of the National Academy of Sciences of the United States of America2026
Leveraging latent space models for enzyme discovery and sampling.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The exponential growth in available protein sequence data has broadened enzyme discovery opportunities but simultaneously highlighted a significant gap between sequence and function information. Traditional tools like phylogenetic trees and sequence similarity networks (SSNs) are widely adopted for sampling enzymes for novel transformations. However, their utility suffers from inherent limitations, which are exacerbated for large enzyme families. Phylogenetic trees, while useful for studying evolutionary relationships, become computationally intensive and difficult to visualize for larger protein datasets. SSNs, on the other hand, are sensitive to user-defined thresholds for sequence clustering and easily fail to capture more distant relationships between clusters. Additionally, both tools are alignment based and cannot capture higher-order interactions between residues. In this study, we address these limitations by optimizing a variational autoencoder (VAE)-based latent space model to visualize and explore enzyme sequence-function landscapes. By training our models on simulated datasets and real enzyme families, such as cyclases and flavin-dependent monooxygenases (FDMOs), we demonstrated that the optimized latent space effectively preserves phylogenetic relationships and enables high-resolution clustering for functionally distinct enzymes. The models further outperform traditional SSNs in capturing local and global relationships in a continuous two-dimensional space, enabling the discovery of multiple uncharacterized FDMOs for oxidative dearomatization and decarboxylative hydroxylation that illustrates their application. Our findings show that low-dimensional latent spaces can serve as valuable tools for enzyme discovery, allowing for interpolation and extrapolation to guide novel enzyme sampling for biocatalytic reactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.